Activators of FLJ37512 function through various biochemical mechanisms to enhance its activity within cellular signaling networks. Certain small molecule activators exert their effects by modulating the levels of intracellular second messengers such as cAMP. By either directly stimulating the production of cAMP or inhibiting its degradation, these molecules can amplify the signaling cascades that converge on FLJ37512, promoting its phosphorylation and consequent activation. Other activators operate through manipulation of protein kinase activity, with some enhancing kinase function to foster phosphorylation events that prime FLJ37512 for activity, while others inhibit specific kinases, creating a compensatory response that can upregulate FLJ37512 activity. The intricate balance of kinase and phosphatase activities plays a pivotal role in the regulation of FLJ37512, as exemplified by compounds that inhibit phosphatase function, leading to a net increase in the phosphorylated and active form of the protein.
Additionally, the regulation of intracellular ion concentrations, particularly calcium, is a critical factor in the activation of FLJ37512. Activators that function as ionophores facilitate the influx of calcium ions, triggering a series of calcium-dependent signaling pathways that can culminate in the activation of FLJ37512. This mechanism underscores the importance of ion gradients in controlling the activity of signaling proteins, where altering the balance of ions can initiate a domino effect through various pathways to modulate the activity of FLJ37512. Other activators interact with G-protein coupled receptors, setting off a chain reaction that not only involves second messengers but also engages multiple kinases and phosphatases, intricately weaving a network of signals that eventually lead to enhanced FLJ37512 function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Phosphodiesterase inhibitor, elevates cAMP by preventing its degradation, thereby potentially enhancing FLJ37512 signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator that may lead to downstream phosphorylation events, influencing the activity of FLJ37512 through phosphorylation-dependent modulation. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
Inhibits protein kinase A (PKA), potentially increasing the activity of FLJ37512 through compensatory mechanisms within cAMP signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent kinases that modulate FLJ37512. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
G-protein activator that can lead to activation of downstream kinases, potentially enhancing the activity of FLJ37512. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases PP1 and PP2A, potentially increasing the phosphorylation and activity of FLJ37512. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Inhibits Na+/K+ ATPase, leading to altered ion gradients and activation of signaling pathways that could enhance FLJ37512 activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad-spectrum kinase inhibitor that could indirectly activate kinases involved in FLJ37512 signaling through negative feedback loops. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Activates adrenergic receptors, causing a cascade that could lead to activation of kinases that modulate FLJ37512 activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Selective PKC inhibitor that may result in the upregulation of FLJ37512 activity through compensatory cellular responses. | ||||||